FDA New Era of Smarter Food Safety Tech-Enabled Traceability Video Series: Supply Chain Technology

  Рет қаралды 7,971

U.S. Food and Drug Administration

U.S. Food and Drug Administration

Күн бұрын

The U.S. Food and Drug Administration (FDA) has published its first video in an educational series focused on how food companies’ use of tech-enabled traceability can enhance food safety and protect consumers from foodborne illness. This resource, focused on supply chain technology, builds upon key themes from the 2021 FDA New Era of Smarter Food Safety Low- or No-Cost Tech-Enabled Traceability Challenge.
Episode 1 of the series features video from five participating companies demonstrating various approaches to low or no cost traceability technologies within diverse parts of the food supply chain. The video showcases how the food industry can help create a more digital, efficient, and safe food system that will benefit both consumers and food producers. The roundtable participants discuss opportunities for firms to voluntarily adopt tracing technologies, harmonize tracing activities, and ways to incentivize the development and implementation of scalable and cost-effective traceability hardware, software, or data analytics platforms.
This video is an important resource for food producers, technology providers, and other interested stakeholders to advance food traceability concepts and support efforts to ultimately achieve end-to-end traceability throughout the food safety system, at low-or-no-cost to the end user, as outlined under the New Era of Smarter Food Safety blueprint.
FDA will use the video series to help educate stakeholders on the importance of supply chain collaboration and to foster important conversations about the opportunities and challenges to achieving tech-enabled traceability and data modernization.
This video series includes companies that participated in the Low-or-no-cost Tech-Enabled Challenge and that expressed interest in participating in this video series. FDA does not endorse any technology, company, or solution, and the views and opinions of the video series participants represent those of the speakers and should not be considered to represent advice or guidance on behalf of FDA. Participating companies in Episode 1 are Morpheus Network, Bamboo Rose, Nira, iFoodDS, Varcode.
Timecodes
0:00 - Introduction
3:10 - Morpheus Network
5:50 - Bamboo Rose
7:53 - Nira
10:38 - iFoodDS
13:35 - Varcode
17:55 - Roundtable Discussion

Пікірлер
Bench to Bedside Chats: Guidance for Industry CGMP for Phase 1 Investigational Drugs
1:29:39
U.S. Food and Drug Administration
Рет қаралды 1,4 М.
How FDA Investigates Foodborne Illness Outbreaks
12:08
U.S. Food and Drug Administration
Рет қаралды 47 М.
АЗАРТНИК 4 |СЕЗОН 4 Серия
36:20
Inter Production
Рет қаралды 491 М.
Как мы играем в игры 😂
00:20
МЯТНАЯ ФАНТА
Рет қаралды 3,2 МЛН
Офицер, я всё объясню
01:00
История одного вокалиста
Рет қаралды 4 МЛН
Importing FDA-Regulated Products: Seafood
16:02
U.S. Food and Drug Administration
Рет қаралды 3,6 М.
An Overview of the Quality Management System Regulation
16:15
U.S. Food and Drug Administration
Рет қаралды 2,8 М.
Semana Nacional de Concientización sobre el Cáncer en las Familias Hispanas/Latinas
1:06:56
U.S. Food and Drug Administration
Рет қаралды 646
Navigating the Quality Management System Regulation
22:26
U.S. Food and Drug Administration
Рет қаралды 1,5 М.
Conversations on Cancer: National Hispanic/Latino Family Cancer Awareness Week
1:01:53
U.S. Food and Drug Administration
Рет қаралды 1 М.
Programa da Semana Nacional de Conscientização sobre o Câncer em Famílias Hispânicas/Latinas
1:07:31
Advancing Generic Drug Development: Translating Science to Approval 2024 (Day 2)
7:01:55
U.S. Food and Drug Administration
Рет қаралды 1,7 М.
Advancing Generic Drug Development: Translating Science to Approval 2024 (Day 1)
7:12:31
U.S. Food and Drug Administration
Рет қаралды 1,8 М.
National Forensic Chemistry Center Revitalized
6:31
U.S. Food and Drug Administration
Рет қаралды 2,7 М.
АЗАРТНИК 4 |СЕЗОН 4 Серия
36:20
Inter Production
Рет қаралды 491 М.